CAR T-Cell Therapy in South Korea
South Korean medical facilities have spearheaded groundbreaking CAR T-cell therapies, ushering in a new era of cancer treatment with personalized approaches for hematologic malignancies and solid tumors.
Revolutionary Cancer Treatment in South Korea
Utilizing cutting-edge biomedical research, South Korean medical facilities have spearheaded groundbreaking CAR T-cell therapies, ushering in a new era of cancer treatment. These innovative interventions cater to patients grappling with hematologic malignancies and solid tumors, showcasing South Korea's prowess in personalized medicine.
By tailoring CAR T-cell treatments to the unique characteristics of each patient, medical centers in South Korea not only boost therapeutic outcomes but also mitigate potential side effects. This progressive methodology highlights South Korea's dedication to propelling oncological healthcare forward.
South Korea has done extensive research and development on CAR T-cell therapy, with numerous clinical trials and treatment centers devoted to this innovative approach. The country's healthcare system and technological expertise have made CAR T-cell therapy successful, giving patients with blood cancers hope and paving the way for more personalized cancer treatments in the region.
Start Your Treatment Journey
How CAR T-Cell Therapy Works
CAR T-cell therapy is a personalized immunotherapy that reprograms a patient's own immune cells to recognize and attack cancer cells.
Blood Collection
T-cells are collected from the patient's blood through a process called leukapheresis
Genetic Engineering
T-cells are genetically modified to produce chimeric antigen receptors (CARs)
Cell Multiplication
CAR T-cells are multiplied in the laboratory to create millions of cancer-fighting cells
Infusion
The engineered CAR T-cells are infused back into the patient's bloodstream
Recent Advances in CAR T-Cell Therapy in Korea
South Korea has emerged as a global leader in CAR T-cell therapy research and implementation.
Clinical Trials Expansion
South Korea has actively pursued clinical trials for CAR T-cell therapy, creating an environment that encourages innovation and patient-centered care. The country has been at the forefront of testing treatments for hematological diseases and solid tumors.
New CAR Construct Development
Korean researchers have been working hard to create new CAR constructs that make CAR T-cell treatment more effective and safer. This includes making improvements to chimeric antigen receptors so CAR T-cells can better target tumors.
Combination Therapies
South Korean researchers have explored combining CAR T-cell therapy with other treatments like immune checkpoint inhibitors and targeted therapies to improve response rates and overcome tumor resistance mechanisms.
Manufacturing Advancements
South Korea has made significant progress in creating robust, scalable manufacturing processes for CAR T-cell therapies, making these treatments more accessible to patients who need them.
Leading CAR T-Cell Companies in South Korea
Korean biotech companies are at the forefront of CAR T-cell therapy innovation and development.
ViroMed
ViroMed announced plans to develop CAR-T drugs utilizing their CAR gene optimization technology, vector production technology, and ex vivo technology for gene transfer and cell proliferation. The company previously sold their CAR-T technology to US Bluebird Bio for 56.8 billion won.
AbClon
Developing a blood cancer treatment based on technology that is safer than current CAR-T drugs by greatly reducing cytokine release syndrome (CRS), a detrimental side effect that can cause hypotension, fever, and even death in patients.
Curocell
A South Korean biotech startup that pioneered CAR-T cell therapy, planning clinical trials of novel CAR-T cell therapy that targets both blood cancer and solid tumors using their OVIS technology to overcome immune suppression in solid tumors.
Green Cross Cell
Screening and validating CAR-T drug candidates for solid cancer treatment with plans to conduct research for pre-clinical trials. Part of the Green Cross corporation with extensive experience in biopharmaceuticals.
Top Hospitals for CAR T-Cell Therapy in Korea
These leading medical centers combine exceptional clinical care with groundbreaking research in CAR T-cell therapy.
Asan Medical Center
Seoul, South Korea
Asan Medical Centre has been at the forefront of using new technologies to treat blood cancer, with the goal of improving patient results and quality of life. The centre has invested in cutting-edge technologies for accurate genetic mapping of tumours.
Samsung Medical Center
Seoul, South Korea
Renowned for its comprehensive cancer center and research institute, Samsung Medical Center has partnered with Curocell for CAR T-cell therapy clinical trials, offering cutting-edge immunotherapy treatments.
Seoul National University Hospital
Seoul, South Korea
As Korea's first modern hospital, SNUH continues to lead in medical innovation with extensive research in CAR T-cell therapy and collaborations with academic institutions for advanced cancer treatments.
Cost of CAR T-Cell Therapy in Korea
Understanding the financial aspects of treatment helps in planning your healthcare journey.
The cost of CAR T-Cell therapy in South Korea starts from $450,000 USD and can reach up to $500,000 USD depending on the type and extent of disease and its burden on the body.
It is crucial to keep in mind that this estimate is only a general approximation and that specific circumstances may change. The precise type of CAR-T therapy, the intricacy of the procedure, hospital costs, supportive care, and additional diagnostic testing are all variables that can affect price.
To control the costs related to CAR-T cell therapy, it is advised for patients to speak with healthcare professionals and look into insurance coverage or financial help programmes.
Apply for CAR T-Cell Therapy in Korea
Start your journey to advanced cancer treatment with our comprehensive support services. We guide you through every step of the process.
Required Documents:
Medical Summary
Detailed medical history and current condition
Latest Blood Reports
Complete blood count and relevant lab tests
Biopsy Report
Pathology report confirming cancer diagnosis
Latest PET Scan
Imaging studies showing disease extent
Bone Marrow Biopsy
If available for hematologic cancers